Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Dis-Chem Pharmacies's earnings per share without non-recurring items for the
six
months ended in Feb. 2026 was R0.40.
Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Feb. 2026 was R1.14.
During the past 12 months, Dis-Chem Pharmacies's average earnings per share (NRI) Growth Rate was -17.30% per year.
During the past 3 years, the average earnings per share (NRI) Growth Rate was -0.80% per year.
During the past 5 years, the average earnings per share (NRI) Growth Rate was 8.50% per year.
During the past 10 years, the average earnings per share (NRI) Growth Rate was 1.70% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.
The historical rank and industry rank for Dis-Chem Pharmacies's EPS without NRI or its related term are showing as below:
JSE:DCP'
s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -33.1 Med: -0.3 Max: 18.7
Current: -0.8
During the past 13 years, Dis-Chem Pharmacies's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 18.70% per year. The lowest was -33.10% per year. And the median was -0.30% per year.
JSE:DCP's 3-Year EPS without NRI Growth Rate is ranked worse than 65.95% of 511
companies
in the Healthcare Providers & Services industry
Industry Median: 11.5
vs JSE:DCP: -0.80
Dis-Chem Pharmacies's EPS (Basic) for the
six
months ended in Feb. 2026 was R0.40.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Feb. 2026 was R1.14.
Dis-Chem Pharmacies (JSE:DCP) EPS without NRI Explanation
EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Dis-Chem Pharmacies EPS without NRI Related Terms
Dis-Chem Pharmacies EPS without NRI Historical Data
* Premium members only.
The historical data trend for Dis-Chem Pharmacies's EPS without NRI can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dis-Chem Pharmacies EPS without NRI Competitor Comparison
For the Pharmaceutical Retailers subindustry, Dis-Chem Pharmacies's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dis-Chem Pharmacies PE Ratio without NRI vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Dis-Chem Pharmacies's PE Ratio without NRI distribution charts can be found below:
* The bar in red indicates where Dis-Chem Pharmacies's PE Ratio without NRI falls into.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.
EPS without NRI for the trailing twelve months (TTM) ended in Feb. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was R1.14
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dis-Chem Pharmacies (JSE:DCP) has a EPS without NRI of R1.14 as of Feb. 2026. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Dis-Chem Pharmacies and its competitors. According to the industry distribution chart, Dis-Chem Pharmacies ranks #337 out of 511 companies in the Healthcare Providers & Services industry, placing it in the top 65.9%.
Is Dis-Chem Pharmacies' EPS without NRI too high?
Dis-Chem Pharmacies' current EPS without NRI is R1.14. Based on the distribution chart, Dis-Chem Pharmacies ranks #337 out of 511 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Dis-Chem Pharmacies has a GF Score™ of 85/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Dis-Chem Pharmacies' EPS without NRI compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Dis-Chem Pharmacies ranks #337 out of 511 companies for EPS without NRI. This places Dis-Chem Pharmacies in the lower half of its industry. The industry median EPS without NRI is 11.50. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Healthcare Providers & Services company?
The median EPS without NRI among Healthcare Providers & Services companies is 11.50, based on 511 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Dis-Chem Pharmacies and its competitors. For the Healthcare Providers & Services industry, the median EPS without NRI is 11.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dis-Chem Pharmacies's current EPS without NRI is R1.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dis-Chem Pharmacies stock overvalued right now?
Based on GuruFocus' analysis, Dis-Chem Pharmacies (JSE:DCP) is currently considered Modestly Undervalued. The stock's GF Value™ is R38.23, compared to a current price of R32.20 — trading 15.8% below its estimated fair value. The current EPS without NRI is R1.14. Dis-Chem Pharmacies' overall GF Score™ is 85/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Dis-Chem Pharmacies (JSE:DCP), the current EPS without NRI is R1.14 as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dis-Chem Pharmacies (JSE:DCP) Overvalued in 2026?
Based on GuruFocus' analysis, Dis-Chem Pharmacies stock appears to be undervalued.
The current stock price of R32.20 is trading 15.8% below its estimated GF Value™ of R38.23.
GuruFocus considers Dis-Chem Pharmacies to be Modestly Undervalued.
Key valuation signals for JSE:DCP:
EPS without NRI: R1.14
GF Value™: R38.23 vs. price of R32.20 (15.8% below fair value)
No single metric tells the full story. See the JSE:DCP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dis-Chem Pharmacies Ltd is a pharmaceutical company based in South Africa. Its product portfolio includes personal care products, beauty products, healthcare and nutrition products, and dispensary and baby care products. The operating segments of the group are Retail and Wholesale. It derives maximum revenue from the Retail segment, which includes company stores, retailers of pharmaceuticals and a variety of health and beauty products, as well as pharma-logistic services and oncology and retailers of pharmaceutical products. The Wholesale segment consists of the CJ wholesale and company distribution businesses, wholesalers of pharmaceuticals, and a variety of health and beauty products. Geographically, the group carries out its business operations principally in South Africa.
85GF Score
Get the complete analysis for JSE:DCP
EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JSE:DCP has been successfully added to your 
